Akarx Inc Drug Patent Portfolio
Akarx Inc owns 2 orange book drugs protected by 3 US patents Given below is the list of Akarx Inc's drug patents along with their expiration dates.
Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
---|---|---|---|
US7638536 | 2-Acylaminothiazole derivative or salt thereof | 28 Jul, 2027 | Active |
US8338429 | 2-acylaminothiazole derivative or salt thereof | 30 Jun, 2023 | Expired |
US8765764 | 2-acylaminothiazole derivative or salt thereof | 15 Jan, 2023 | Expired |
Latest Legal Activities on Akarx Inc's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Akarx Inc.
Activity | Date | Patent Number |
---|---|---|
![]() | ||
Patent Term Extension Certificate
Critical
| 08 Jan, 2024 | US7638536 |
Resp. to req. for info. sent under 37 CFR 1.750 | 26 Dec, 2023 | US7638536 |
Requirement for information sent under 37 CFR 1.750 | 08 Dec, 2023 | US7638536 |
Notice of Final Determination -Eligible | 16 Nov, 2023 | US7638536 |
FDA Final Eligibility Letter
Critical
| 14 Nov, 2023 | US7638536 |
transaction for FDA Determination of Regulatory Review Period | 06 Feb, 2023 | US7638536 |
transaction for FDA Determination of Regulatory Review Period | 02 Feb, 2023 | US7638536 |
Information Disclosure Statement (IDS) Filed
Critical
| 02 Feb, 2023 | US7638536 |
Interim Patent Term Extension Granted
Critical
| 11 Jan, 2023 | US7638536 |
PARALEGAL OR ELECTRONIC TERMINAL DISCLAIMER APPROVED
Critical
| 09 Jan, 2023 | US7638536 |
Terminal Disclaimer Filed
Critical
| 09 Jan, 2023 | US7638536 |
Payment of Maintenance Fee, 8th Year, Large Entity | 22 Dec, 2021 | US8765764 |
Payment of Maintenance Fee, 12th Year, Large Entity | 21 Jun, 2021 | US7638536 |
Second letter to regulating agency to determine regulatory review period | 26 Apr, 2021 | US7638536 |
Payment of Maintenance Fee, 8th Year, Large Entity | 16 Jun, 2020 | US8338429 |
Akarx Inc's Family Patents

Akarx Inc Drug List
Given below is the complete list of Akarx Inc's drugs and the patents protecting them.
1. Doptelet
Doptelet is protected by 3 patents, out of which 2 have expired. Check out its patent list below.
Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
---|---|---|---|
US7638536 | 2-Acylaminothiazole derivative or salt thereof |
28 Jul, 2027
(1 year, 9 months from now)
| Active |
US8338429 | 2-acylaminothiazole derivative or salt thereof |
30 Jun, 2023
(2 years ago)
| Expired |
US8765764 | 2-acylaminothiazole derivative or salt thereof |
15 Jan, 2023
(2 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Doptelet's drug page
2. Doptelet Sprinkle
Doptelet Sprinkle is protected by 1 patent, which is still active. Check out its patent list below.
Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
---|---|---|---|
US7638536 | 2-Acylaminothiazole derivative or salt thereof |
28 Jul, 2027
(1 year, 9 months from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Doptelet Sprinkle's drug page